Back to
Renaissance Technologies LLC
AGRX
2 quarters
Position history for
Renaissance Technologies LLC's holdings in AGILE THERAPEUTICS INC
No. Renaissance Technologies exited its AGRX (Agile Therapeutics) position in Q1 2024. Its Q4 2023 13F listed 59,200 shares worth $115,000. Renaissance Technologies first reported AGRX in Q4 2023 and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
-$115,000
Total Shares Change
-59,200
Quarter-by-Quarter History